A federal judge has tossed, with leave to amend, the bulk of a federal racketeering and fraud class action brought by an Ohio-based health insurer against Abbvie and other makers of testosterone drugs, saying the insurer has not yet backed up with enough particularity its allegations the drugmakers invented the condition known as “low T,” and, through false marketing to doctors, patients and insurers alike, induced insurers and others to pay far more for the drugs to treat the condition.
Judge declines to drop Androgel maker Besins from huge lawsuit over testosterone treatment side effects
A federal judge has declined to drop the Belgian company which makes Androgel and its American licensee from a multi-state class action lawsuit, which alleges the companies’ testosterone restorative drug is not only useless, but harmful. However, the judge did leave the door open that jurisdiction over the case could lay elsewhere.
The online sale of five hotel properties worth a combined $86 million is proceeding after a federal judge in Chicago approved the transaction, which is connected to an ongoing lawsuit regarding a multi-million dollar fraudulent loan scheme. Pennant Management is embroiled in legal proceedings after accusing First Farmers Financial of selling it the federally guaranteed portions of 26 fraudulent loans allegedly worth $180 million.